Education
About Us
Working with TipRanks
Follow Us
Amplifon S.p.A. (GB:0N61)
LSE:0N61
0N61 Stock Chart & Stats
€12.96
-€0.64(-2.45%)
At close: 4:00 PM EST
€12.96
-€0.64(-2.45%)
Day’s Range― - ―
52-Week Range€12.67 - €24.98
Previous CloseN/A
Volume73.02K
Average Volume (3M)88.45K
Market Cap
€2.90B
Enterprise Value€4.51B
Total Cash (Recent Filing)€237.31M
Total Debt (Recent Filing)€1.89B
Price to Earnings (P/E)25.1
Beta0.83
Next Earnings
Mar 04, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding226,388,630
10 Day Avg. Volume39,207
30 Day Avg. Volume88,446
Financial Highlights & Ratios
PEG Ratio-5.33
Price to Book (P/B)4.88
Price to Sales (P/S)2.33
P/FCF Ratio15.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€15.30Price Target Upside18.06% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.84
Revenue Forecast (FY)€2.52B
Bulls Say, Bears Say
Bulls Say
Cash Flow GenerationStrong free cash flow growth indicates improved cash generation capabilities, providing financial flexibility for reinvestment and debt reduction.
Business Model StrengthThe direct-to-consumer model enhances customer engagement and control over distribution, supporting stable revenue streams and market presence.
Partnerships And AlliancesPartnerships with manufacturers allow access to diverse products and competitive pricing, strengthening market position and customer offerings.
Bears Say
Declining RevenueNegative revenue growth suggests challenges in sales expansion, potentially impacting long-term profitability and market share.
Profitability MarginsDecreased net profit margins indicate reduced profitability, which may affect the company's ability to invest in growth and innovation.
High LeverageHigh leverage can pose financial risks, limiting the company's ability to manage economic downturns and invest in strategic opportunities.
Amplifon S.p.A. News
0N61 FAQ
What was Amplifon S.p.A.’s price range in the past 12 months?
Amplifon S.p.A. lowest share price was €12.66 and its highest was €24.98 in the past 12 months.
What is Amplifon S.p.A.’s market cap?
Amplifon S.p.A.’s market cap is €2.90B.
When is Amplifon S.p.A.’s upcoming earnings report date?
Amplifon S.p.A.’s upcoming earnings report date is Mar 04, 2026 which is in 5 days.
How were Amplifon S.p.A.’s earnings last quarter?
Amplifon S.p.A. released its earnings results on Oct 29, 2025. The company reported €0.086 earnings per share for the quarter, the consensus estimate of €0.086 by €0.
Is Amplifon S.p.A. overvalued?
According to Wall Street analysts Amplifon S.p.A.’s price is currently Undervalued.
Does Amplifon S.p.A. pay dividends?
Amplifon S.p.A. does not currently pay dividends.
What is Amplifon S.p.A.’s EPS estimate?
Amplifon S.p.A.’s EPS estimate is 0.23.
How many shares outstanding does Amplifon S.p.A. have?
Amplifon S.p.A. has 226,388,630 shares outstanding.
What happened to Amplifon S.p.A.’s price movement after its last earnings report?
Amplifon S.p.A. reported an EPS of €0.086 in its last earnings report, expectations of €0.086. Following the earnings report the stock price went down -2.25%.
Which hedge fund is a major shareholder of Amplifon S.p.A.?
Currently, no hedge funds are holding shares in GB:0N61
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amplifon S.p.A.
Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
0N61 Stock 12 Month Forecast
Average Price Target
€15.30
▲(18.06% Upside)
Technical Analysis
PharmaNutra SpA
―
Health Italia SpA
―
Garofalo Health Care S.P.A.
―
GPI SpA
―
Svas Biosana S.p.A.
―
Options Prices
Currently, No data available
---